Jump to content

Medical Update


Guest

Recommended Posts

  • Replies 183
  • Created
  • Last Reply

ADTN

 

 

S&P Equity anal cyst Downgrades Opinion on Adtran to 'Sell'

Wednesday January 15, 2:41 pm ET

Unwarranted Premium Valuation Cited

 

 

NEW YORK, Jan. 15 /PRNewswire/ -- Standard & Poor's has downgraded its equity STARS ranking on Adtran (Nasdaq: ADTN - News) from a three-STARS "Hold" to a one-STARS "Sell." A leading provider of independent research, indices and ratings, Standard & Poor's made this announcement through Standard & Poor's MarketScope, its real-time market intelligence service.

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

  • Tell a friend

    Love Stool Pigeons Wire Message Board? Tell a friend!
  • Recently Browsing   0 members

    • No registered users viewing this page.
  • ×
    • Create New...